Amaurosis fugax

MONDO:0043310

Transient complete or partial monocular blindness due to retinal ischemia. This may be caused by emboli from the CAROTID ARTERY (usually in association with CAROTID STENOSIS) and other locations that enter the central RETINAL ARTERY. (From Adams et al., Principles of Neurology, 6th ed, p245)

Also known as: amaurosis fugax, amaurosis fugax (one sided temporary vision loss), blindness, monocular, transient, blindness, transient monocular, momentary blindness, monocular blindness, transient, transient monocular blindness

16 clinical trials for this condition and its sub-types.

Follow this condition — get notified about new trials

Broader categories

Disease (618) Nervous system disorder (217) Vision disorder (85) Blindness (disorder) (33) Perceptual disorders (21) Human disease (14) Disorder of visual system (1) Disease by body system or component (0)

Trials to join now! 4 Not yet recruiting 3 Not yet finished but already full! 5 Completed 3 Terminated 1

VR headsets tested as a possible treatment for blindness

Disease control Terminated

This study tested whether using a virtual reality headset for one-hour sessions could help regenerate damaged optic nerves and improve vision in people with glaucoma or other retinal diseases. The idea came from promising results in rodents. However, the trial was terminated earl…

Phase: NA • Sponsor: Stanford University • Aim: Disease control

Last updated Jun 27, 2026 08:03 UTC

Amaurosis fugax

Broader categories

VR headsets tested as a possible treatment for blindness